Endogenous nitric oxide does not modulate mesenteric mast cell degranulation in rats

Biochemical Pharmacology

Volumn 65, Issue 12, 2003, Pages 2073-2080

  Kwasniewski, Fábio H ^a   Tavares De Lima, Wothan ^a   Bakhle, Y S ^b   Jancar, Sonia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Anaphylaxis; Mast cells; Nitric oxide; Spontaneously hypertensive rat; Vascular permeability

Indexed keywords

EVANS BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OVALBUMIN; TOLONIUM CHLORIDE;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DEGRANULATION; DRUG EFFECT; DUODENUM; EXTRAVASATION; MALE; MAST CELL; MESENTERY; MICROSCOPY; MODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; SKIN; STAINING;

EID: 0037716235     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00191-6     Document Type: Article

References (28)

1. Kwasniewski F.H., Tavares de Lima W., Bakhle Y.S., Jancar S. Impairment in connective tissue mast cells degranulation in spontaneously hypertensive rats: stimulus dependent resistance. Br. J. Pharmacol. 124:1998;772-778.
2. Coleman J.W. Nitric oxide: a regulator of mast cell activation and mast cell mediated inflammation. Clin. Exp. Immunol. 129:2002;1-10.
3. Deschoolmeester M.L., Eastmond N.C., Dearman R.J., Kimber I., Basketter D.A., Coleman J.W. Reciprocal effects of interleukin-4 and interferon gamma on immunoglobulin E-mediated mast cell degranulation: a role for nitric oxide but not peroxynitrite or cyclic guanosine monophosphate. Immunology. 96:1999;138-144.
4. Brooks A.C., Whelan C.J., Purcell W.M. Reactive oxygen species generation and histamine release by activated mast cells; modulation by nitric oxide synthase inhibition. Br. J. Pharmacol. 128:1999;585-590.
5. Koranteng R.D., Dearman R.J., Kimber I., Coleman J.W. Phenotypic variation in mast cell responsiveness to the inhibitory action of nitric oxide. Inflamm. Res. 49:2000;240-246.
6. Gaboury J.P., Niu X.-F., Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation. 93:1996;318-326.
7. Stenton G.R., Vliagoftis H., Befus A.D. Role of intestinal mast cell in modulating gastrointestinal pathophysiology. Annu. Allergy Asthma Immunol. 81:1998;1-15.
8. G-nitro arginine produces an exaggerated hypertension in anesthetized SHR. Eur. J. Pharmacol. 197:1991;239-240.
9. Lee L., Webb R.C. Endothelium-dependent relaxation and L-arginine metabolism in genetic hypertension. Hypertension. 19:1992;435-441.
10. Masini E., Mannaioni P.F., Pistelli A., Salvemini D., Vane J.R. Impairment of the L-arginine-nitric oxide pathway in mast cells from spontaneously hypertensive rats. Biochem. Biophys Res. Commun. 177:1991;1178-1182.
11. Xiao J., Pang P.K.T. Activation of nitric oxide synthesis in vascular smooth muscle cells and macrophages during development in spontaneously hypertensive rats. Am. J. Hypertens. 9:1996;377-384.
12. Metcalfe D.D., Baram D., Mekori Y.A. Mast cells. Physiol. Rev. 77:1997;1033-1079.
13. Sirois M.G., Jancar S., Braquet P., Plante G.E., Sirois P. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. Prostaglandins. 36:1988;631-644.
14. Mota I., Dias da Silva W. Antigen-induced damage to isolated sensitized mast cells. Nature. 186:1960;245-246.
15. Mota I., Wong D. Homologous and heterologous passive cutaneous anaphylactic activity of mouse antisera during the course of immunization. Life Sci. 8:1969;813-820.
16. Hobbs A.J., Higgs A., Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu. Rev. Pharmacol. Toxicol. 39:1999;191-220.
17. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7:1989;59-76.
18. Eastmond N.C., Banks E.M.S., Coleman J.W. Nitric oxide inhibits IgE-mediated degranulation of mast cell and is the principal intermediate in IFN-γ-induced suppression of exocytosis. J. Immunol. 159:1997;1444-1450.
19. Kruger-Krasagakes S., Grutzkau A., Krasagakis K., Hoffmann S., Henz B.M. Adhesion of human mast cells to extracellular matrix provides a co-stimulatory signal for cytokine production. Immunology. 98:1999;253-257.
20. Mannaioni P.F., Masini E., Pistelli A., Salvemini D., Vane J.R. Mast cells as a source of superoxide anions and nitric oxide-like factor: relevance to histamine release. Int. J. Tissue React. 13:1991;271-278.
21. Kubes P., Kanwar S., Niu X.-F., Gaboury J.P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7:1993;1293-1299.
22. Al-Naemi H., Baldwin A.L. Nitric oxide: role in venular permeability recovery after histamine challenge. Am. J. Physiol. 277:1999;H2010-2016.
23. Yamaki K., Thorlacius H., Xie X., Lindbom L., Hedqvist P., Raud J. Characteristics of histamine-induced rolling in the undisturbed microcirculation of the rat mesentery. Br. J. Pharmacol. 123:1998;390-399.
24. Kosaka H., Seiyama A., Terada N., Yoneyama H., Hirota S., Kitamura Y. Absence of mast cell involvement in leukocyte adhesion and emigration induced by inhibition of nitric oxide synthesis. Lab. Invest. 77:1997;575-580.
25. Kimura M., Mitani H., Bandoh T., Totsuka T., Hayashi S. Mast cell degranulation in rat mesenteric venule: effects of L-NAME, methylene blue and ketotifen. Pharmacol. Res. 39:1999;397-402.
26. Peh K.H., Moulson A., Wan B.Y., Assem E.K., Pearce F.L. Role of nitric oxide in histamine release from human basophils and rat peritoneal mast cells. Eur. J. Pharmacol. 425:2001;229-238.
27. Hughes S.R., Brain S.D., Williams T.J. Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur. J. Pharmacol. 191:1990;481-484.
28. Kajekar R., Moore P.K., Brain S.D. Essential role for nitric oxide in neurogenic inflammation in rat cutaneous microcirculation. Evidence for an endothelium-independent mechanism. Circ. Res. 76:1995;441-447.